MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.010
-0.040 (-1.31%)
At close: Apr 28, 2026, 4:00 PM EDT
3.033
+0.023 (0.76%)
After-hours: Apr 28, 2026, 6:53 PM EDT
MacroGenics Employees
MacroGenics had 293 employees as of December 31, 2025. The number of employees decreased by 48 or -14.08% compared to the previous year.
Employees
293
Change (1Y)
-48
Growth (1Y)
-14.08%
Revenue / Employee
$510,239
Profits / Employee
-$254,676
Market Cap
191.32M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| Karyopharm Therapeutics | 228 |
| MediWound | 121 |
| Nkarta | 108 |
| Caribou Biosciences | 97 |
| OmniAb | 89 |
| Enlivex | 34 |
| Elicio Therapeutics | 33 |
MGNX News
- 20 days ago - FDA Removes Partial Clinical Hold on MacroGenics' LINNET Study - GlobeNewsWire
- 6 weeks ago - MacroGenics Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 6 weeks ago - MacroGenics Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 7 weeks ago - MacroGenics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures - GlobeNewsWire
- 2 months ago - MacroGenics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - MacroGenics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial - GlobeNewsWire